Detalles de la búsqueda
1.
Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race.
Oncologist
; 27(10): e815-e818, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36036607
2.
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer.
Cancer
; 127(16): 2954-2965, 2021 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33951180
3.
Germline BLM mutations and metastatic prostate cancer.
Prostate
; 80(2): 235-237, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31816118
4.
PSMA ADC monotherapy in patients with progressive metastatic castration-resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open-label single-arm phase 2 study.
Prostate
; 80(1): 99-108, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31742767
5.
Metastatic castration-sensitive prostate cancer: Abiraterone, docetaxel, or .
Cancer
; 125(11): 1777-1788, 2019 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30933324
6.
Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancer.
Cancer
; 125(23): 4172-4180, 2019 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31483485
7.
The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer.
Cancer
; 123(18): 3532-3539, 2017 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28608931
8.
A Medical Pearl Harbor: Pandemic Uncovers Societal Fissures and Leadership Breaches.
Oncologist
; 26(2): 89, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33438780
9.
PSMA-targeted radiotherapy in metastatic castration-resistant prostate cancer.
Clin Adv Hematol Oncol
; 19(8): 494-496, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34411067
10.
Prostate-Specific Membrane Antigen-Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of 225Ac-J591.
J Clin Oncol
; 42(7): 842-851, 2024 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37922438
11.
External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 Trial.
Eur Urol Oncol
; 2024 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38302323
12.
Prostate specific antigen best practice statement: 2009 update.
J Urol
; 189(1 Suppl): S2-S11, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23234625
13.
Longitudinal Monitoring of Circulating Tumor DNA to Assess the Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Genitourinary Malignancies.
JCO Precis Oncol
; 7: e2300131, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37467457
14.
Urologists and oncologists: adapting to a new treatment paradigm in castration-resistant prostate cancer (CRPC).
BJU Int
; 110(3): 328-35, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22712568
15.
Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancer.
Med Oncol
; 39(5): 63, 2022 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35478055
16.
The Influence of the Pretreatment Immune State on Response to Radiation Therapy in High-Risk Prostate Cancer: A Validation Study From NRG/RTOG 0521.
Int J Radiat Oncol Biol Phys
; 114(2): 266-274, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35675855
17.
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial.
Lancet
; 376(9747): 1147-54, 2010 Oct 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-20888992
18.
Differential Activity of PARP Inhibitors in BRCA1- Versus BRCA2-Altered Metastatic Castration-Resistant Prostate Cancer.
JCO Precis Oncol
; 52021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34778690
19.
Evaluation of the genomic alterations in the androgen receptor gene during treatment with high-dose testosterone for metastatic castrate-resistant prostate cancer.
Oncotarget
; 11(1): 15-21, 2020 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32002120
20.
Overall Survival in Men With Bone Metastases From Castration-Resistant Prostate Cancer Treated With Bone-Targeting Radioisotopes: A Meta-analysis of Individual Patient Data From Randomized Clinical Trials.
JAMA Oncol
; 6(2): 206-216, 2020 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31830233